Nevia Bio

Nevia Bio is a diagnostics company, developing early detection tests for gynecologic cancers by analyzing vaginal fluid. Unlike blood-based tests, vaginal fluid is in close proximity to the tumor site and carry stronger signals at earlier stages of the disease. We use AI and a multi-omics approach to detect and monitor these biomarkers and to guide more effective treatments, leading to significantly better outcomes for patients. Our tests are non-invasive and are designed for patient self-collection, eliminating the need for unnecessary blood drawings, clinical visits, or invasive procedures. We are redefining what's possible in cancer care for women, starting with ovarian cancer and expanding to a broad range of gynecologic malignancies.